Target guided isolation, in-vitro antidiabetic, antioxidant activity and molecular docking studies of some flavonoids from Albizzia Lebbeck Benth. bark

BMC Complementary and Alternative Medicine

Volumn 14, Issue , 2014, Pages

  Ahmed, Danish ^a   Kumar, Vikas ^a   Sharma, Manju ^b,c   Verma, Amita ^a  

^a SAM HIGGINBOTTOM UNIVERSITY OF AGRICULTURE   (India)

^b HAMDARD UNIVERSITY   (India)

^c HAMDARD UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; 5 DEOXYFLAVONE; ALBIZIA LEBBECK EXTRACT; ALPHA GLUCOSIDASE; AMYLASE; ANTIDIABETIC AGENT; FLAVONOID; GLUCOSE; ISOOKANIN; LUTEOLIN; PLANT EXTRACT; SILICA GEL; UNCLASSIFIED DRUG; ANTIOXIDANT; CHALCONE DERIVATIVE; GLYCOSIDASE INHIBITOR; METHANOL;

ALBIZIA LEBBECK; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BARK; BINDING AFFINITY; CARBON NUCLEAR MAGNETIC RESONANCE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DPPH RADICAL SCAVENGING ASSAY; DRUG EFFICACY; DRUG ISOLATION; DRUG PURIFICATION; DRUG SCREENING; DRUG STRUCTURE; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; HYDROGEN BOND; IC 50; IN VITRO STUDY; MASS SPECTROMETRY; MOLECULAR DOCKING; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN EXPRESSION; PROTON NUCLEAR MAGNETIC RESONANCE; ALBIZIA; ANTAGONISTS AND INHIBITORS; CHEMICAL STRUCTURE; CHEMISTRY; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; ISOLATION AND PURIFICATION; OXIDATION REDUCTION REACTION; PHYTOTHERAPY;

ALBIZZIA; ALPHA-AMYLASES; ALPHA-GLUCOSIDASES; ANTIOXIDANTS; CHALCONES; DIABETES MELLITUS, TYPE 2; FLAVONOIDS; GLYCOSIDE HYDROLASE INHIBITORS; HYPOGLYCEMIC AGENTS; LUTEOLIN; METHANOL; MOLECULAR DOCKING SIMULATION; MOLECULAR STRUCTURE; OXIDATION-REDUCTION; PHYTOTHERAPY; PLANT BARK; PLANT EXTRACTS;

EID: 84902660160     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-14-155     Document Type: Article

References (46)

1. Astrup A. Healthy lifestyles in Europe: prevention of obesity and type II diabetes by diet and physical activity. Public Health Nutr 2001, 4:499-515.
2. Bazzano L, Serdula MLS. Prevention of type 2 diabetes by diet and lifestyle modification. J Am Coll Nutr 2005, 24:310-319. 10.1080/07315724.2005.10719479, 16192254.
3. Ahmed D, Sharma M, Mukerjee A, Ramteke PW, Kumar V. Improved glycemic control, pancreas protective and hepatoprotective effect by traditional poly-herbal formulation " Qurs Tabasheer" in streptozotocin induced diabetic rats. BMC Complement Altern Med 2013, 13:10. 10.1186/1472-6882-13-10, 3564698, 23305114.
4. Boden G, Shulman G. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 2002, 32:14-23. 10.1046/j.1365-2362.32.s3.3.x, 12028371.
5. Kumar V, Ahmed D, Gupta PS, Anwar F, Mujeeb M. Anti-diabetic, anti-oxidant and antihyperlipidemic activities of Melastoma malabathricum Linn. leaves in streptozotocin induced diabetic rats. BMC Complement Altern Med 2013, 13:222. 10.1186/1472-6882-13-222, 3847142, 24010894.
6. McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002, 51:7-18. 10.2337/diabetes.51.1.7, 11756317.
7. Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo R. Beta-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab 2005, 90:493-500. 10.1210/jc.2004-1133, 15483086.
8. Whiting DR, Guariguata L, Weil C, Shaw J. IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011, 94:311-321. 10.1016/j.diabres.2011.10.029, 22079683.
9. Anjana RM, Pradeepa R, Deepa M, Datta M, Sudha V, Unnikrishnan R, Bhansali A, Joshi SR, Joshi PP, Yajnik CS, Dhandhania VK, Nath LM, Das AK, Rao PV, Madhu SV, Shukla DK, Kaur T, Priya M, Nirmal E, Parvathi SJ, Subhashini S, Subashini R, Ali MK, Mohan V. On behalf of the ICMR-INDIAB Collaborative Study Group. Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: Phase I results of the Indian Council of Medical Research-India DIABetes (ICMR-INDIAB) study. Diabetologia 2011, 54:3022-3027. 10.1007/s00125-011-2291-5, 21959957.
10. Nelson ME, Rejeski WJ, Blair SN, Duncan PW, Judge JO, King AC, Macera CA, Castaneda-Sceppa C. Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Circulation 2007, 116(9):1094.
11. Bailey C, Day C. Metformin: its botanical background. Pract Diab Int 2004, 21:115-117.
12. Krishnaiah D, Sarbatly R, Nithyanandam R. A review of the antioxidant potential of medicinal plant species. Food Bioprod Process 2010, 89:217-233.
13. Mudaliar KSM. Siddha Materia Medica 1936, 799-800. Chennai: Department of Indian Medicine and Homeopathy.
14. Nadkarni AK. Dr. K.M. Nadkarni's Indian Materia Medica 1954, Bombay, India: Popular Book Depot.
15. Gupta RS, Chaudhary R, Yadav RK, Verma SK, Dhobal MP. Effect of Saponins of Albizia lebbeck Benth. Bark on the reproductive system of male albino rats. J Ethnopharmacol 2005, 96:31-36. 10.1016/j.jep.2004.07.025, 15588647.
16. Mohammad F, Singh PP, Irchhaiya R. Review On Albizia Lebbeck A Potent Herbal Drug. Int Res J Pharm 2012, 3:5.
17. Jung MJ, Kang SS, Jung HA, Kim GJ, Choi JS. Isolation of flavonoids and a cerebroside from the stem bark of Albizzia julibrissin. Arch Pharm Res 2004, 27:593-599. 10.1007/BF02980155, 15283458.
18. Akgul E, Ilham N, Halifeoglu IL. Plasma lipid peroxide levels and antioxidant enzyme activities in type II diabetics: relationship with diabetic microagiopatic complications. Atherosclerosis 1997, 130(suppl 1):9.
19. Karumi Y, Onyeyili PA, Ogugbuaja VO. Identification of active Principles of M. balsamina (Balsam Apple) Leaf Extract. Int J Med Sci 2004, 4:179-182.
20. Soro TY, Traore F, Datte JY, Nene-Bi AS. Activité antipyrétique de l'extrait aqueux de Ximenia americana. Phytother 2009, 7:297-303.
21. Naima S, Khan MR, Maria S. Antioxidant activity, total phenolic and total flavonoid contents of whole plant extracts Torilis leptophylla L. BMC Complement Altern Med 2012, 12:221. 10.1186/1472-6882-12-221, 3524761, 23153304.
22. Park Y-S, Jung S-T, Kang S-G, Heo BK, Arancibia-Avila P, Toledo F, Drzewiecki J, Namiesnik J, Gorinstein S. Antioxidants and proteins in ethylene-treated kiwifruits. Food Chem 2008, 107:640-648.
23. Feng J, Yang XW, Wang RF. Bio-assay guided isolation and identification of α-glucosidase inhibitors from the leaves of Aquilaria sinensis. Phytochemistry 2011, 72:242-247. 10.1016/j.phytochem.2010.11.025, 21215978.
24. Wan L-S, Chen C-P, Xiao Z-Q, Wang Y-L, Min Q-X, Yue Y, Chen J. In vitro and in vivo anti-diabetic activity of Swertia kouitchensis extract. J Ethnopharmacol 2013, 147:622-630. 10.1016/j.jep.2013.03.052, 23567032.
25. Zhang Y, Li Q, Xing H, Xuefeng L, Zhao L, Kankan Q, Bi K. Evaluation of antioxidant activity of ten compounds in different tea samples by means of an on-line HPLC-DPPH assay. Food Res Int 2013, 53:847-856.
26. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods 1997, 44:235-249.
27. Venkatachalam CM, Jiang X, Oldfield T, Waldman M. LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites. J Mol Graph Model 2003, 21:289-307. 10.1016/S1093-3263(02)00164-X, 12479928.
28. Lee SJ, Kim HE, Choi SE, Shin HC, Kwag WJ, Lee BK, Cho KW, Kang Y. Involvement of Ca2 +/calmodulin kinase II (CaMK II) in genistein-induced potentiation of leucine/glutamine-stimulated insulin secretion. Mol Cells 2009, 28:167-174. 10.1007/s10059-009-0119-7, 19756396.
29. Cantero G, Campanella C, Mateos S, Cortés F. Topoisomerase II inhibition and high yield of end reduplication induced by the flavonoids luteolin and quercetin. Mutagenesis 2006, 5:321-325.
30. Ross JA, Kasum CM. Dietary flavonoids: Bioavailability, metabolic effects, and safety. Annu Rev Nutr 2002, 22:19-34. 10.1146/annurev.nutr.22.111401.144957, 12055336.
31. Gui-Yuan L, Yan-Ping Z, Jian-Li G, Jing-Jing Y, Jing L, Zhi-Ru Z, Bo L, Ruan-Juan Z, Su-Hong C. Combined antihypertensive effect of luteolin and buddleoside enriched extracts in spontaneously hypertensive rats. J Ethnopharmacol in press.
32. Fernandez SP, Wasowski C, Loscalzo LM, Granger RE, Johnston GA, Paladini AC, Marder M. Central nervous system depressant action of flavonoid glycosides. Eur J Pharmacol 2006, 539:168-176. 10.1016/j.ejphar.2006.04.004, 16698011.
33. Heim KE, Tagliaferro AR, Bobliya DJ. Flavonoids antioxidants: chemistry, metabolism and structure-activity relationship. J Nutr Biochem 2002, 13:572-584. 10.1016/S0955-2863(02)00208-5, 12550068.
34. Hollman PC, Katan MB. Dietary flavonoids: intake, health effects and bioavailability. Food Chem Toxicol 1999, 37:937-942. 10.1016/S0278-6915(99)00079-4, 10541448.
35. Cushnie TP, Lamb AJ. Antimicrobial activity of flavonoids. Int J Antimicrob Agents 2005, 26:343-356. 10.1016/j.ijantimicag.2005.09.002, 16323269.
36. Hanhineva K, Torronen R, Bondia-Pons I, Pekkinen J, Kolehmainen M, Mykkanen H, Poutanen K. Impact of dietary polyphenols on carbohydrate metabolism. Int J Mol Sci 2010, 11:1365-1402. 10.3390/ijms11041365, 2871121, 20480025.
37. Wedick NM, Pan A, Cassidy A, Rimm EB, Sampson L, Rosner B, Willet W, Hu FB, Sun Q, Dam RMV. Dietary flavonoid intakes and risk of type 2 diabetes in US men and women. Am J Clin Nutr 2012, 95:925-933. 10.3945/ajcn.111.028894, 3302366, 22357723.
38. Dhital S, Lin AH-M, Hamaker BR, Gidley MJ, Muniandy A. Mammalian mucosal α-glucosidases coordinate with α-amylase in the initial starch hydrolysis stage to have a role in starch digestion beyond glucogenesis. PLoS One 2013, 8(4):e62546. 10.1371/journal.pone.0062546, 3636141, 23638112.
39. Kwon YI, Apostolidis E, Kim YC, Shetty K. Health benefits of traditional corn, beans and pumpkin: In vitro studies for hyperglycemia and hypertension management. J Med Food 2007, 10:266-275. 10.1089/jmf.2006.234, 17651062.
40. Kim JS, Kwon CS, Son KH. Inhibition of alpha glucosidase and amylase by luteolin, a flavonoid. Biosci Biotechnol Biochem 2000, 64:2458-2461. 10.1271/bbb.64.2458, 11193416.
41. Baron AD. Postprandial hyperglycaemia and a-glucosidase inhibitors. Diabetes Res Clin Pract 1998, 40:51-55.
42. Casirola DM, Ferraris RP. a-Glucosidase inhibitors prevent diet induced increases in intestinal sugar transport in diabetic mice. Metabolism 2006, 55:832-841. 10.1016/j.metabol.2006.02.011, 16713445.
43. Liu RH, Adom KK. Antioxidant activity of grains. J Agric Food Chem 2002, 50:6182-6187. 10.1021/jf0205099, 12358499.
44. Maria SMR, Fabiano ANF, Ricardo EA, de Brito ES. Free radical scavenging behavior of some north-east Brazilian fruits in a DPPH system. Food Chem 2009, 114:693-695.
45. Anderson RA, Evans ML, Ellis GR, Graham J, Morris K, Jackson SK, Lewis MJ, Rees A, Frenneaux MP. The relationship between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes. Atherosclerosis 2001, 154:475-483. 10.1016/S0021-9150(00)00499-8, 11166782.
46. Devasagayam TPA, Tilak JC, Boloor KK, Sane KS, Ghaskadbi SS, Lele RD. Free radicals and antioxidants in human health: current status and future prospects. J Assoc Physicians India 2004, 52:794-804.